ReviewFrontiers in pharmacology2026
Gut microbiota and spleen-strengthening and dampness-dispelling therapies in obesity and related metabolic disorders: key mechanisms and therapeutic potential.
Review in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Identification of Potential Pancreatic Lipase Inhibitors from Traditional Chinese Medicines via Molecular Docking, Molecular Dynamics Simulation and In Vitro Validation.Current issues in molecular biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Obesity, characterized by excessive body fat and systemic low-level inflammation, is closely linked to energy imbalance and gut dysbiosis. Traditional Chinese medicine (TCM) attributes obesity to spleen deficiency and dampness excess, advocating "strengthening the spleen and expelling dampness" as the core treatment strategy. Studies have shown that TCM formulas, botanical drugs, and their active metabolites can significantly enhance the balance of the gut microbiota, correcting lipid and glucose metabolism disorders, and effectively reducing chronic inflammation and oxidative stress. This study summarizes and concludes relevant research, systematically elaborating on the relationships among TCM formulas, botanical drugs, their metabolites for strengthening the spleen and dispelling dampness, and the gut microbiota. Try to elucidate their effects on obesity by regulating the gut microbiota.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.